We also showed that both monovalent and bivalent IAP antagonists including linker-extended compounds induced cIAP1 depletion and promoted RIPK1:caspase-8 complex formation, which correlated with their ability to degrade GFP-cIAP1 and induce cytotoxicity in cancer cell lines. The gene discussed is RIPK1; the disease is cancer.